Product Theater Schedule
October 15 –23 | |
Thursday, October 15 | |
5:15 pm – 6:00 pm ET |
Selecting a First-in-Class Oral Therapy for Patients With HR+/HER2- Metastatic Breast CancerDesiree Grogan, RPA-C, MSHS Patient Ambassador Veronica E. Pfizer Oncology |
Friday, October 16 | |
3:45 pm –4:30 pm ET |
Treatment Options for the Management of Certain Patients with First-Line Non-Small Cell Lung CancerNancy Gudex, MSN, ANP-BC, AOCNP Bristol Myers Squibb |
Saturday, October 17 | |
1:30 pm –2:15 pm ET |
Pharmacyclics and Janssen Present: The Leukemia & Lymphoma Society Patient Resources: Assisting Blood Cancer Patients and Their FamiliesKaren Demairo, MHSA, Vice President Aaron Kaplowitz, MS, MBA Gigi Bellamy, MSN, RN, OCN Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc. |
Sunday, October 18 | |
2:00 pm– 2:45 pm ET |
Advanced Practice Providers and Their Role in Management of Patients with Bone MetastasesJacob K. Kettle, PharmD, BCOP Amgen |
Monday, October 19 | |
11:30 am– 12:15 pm ET |
Advancements in the Treatment of Lung CancerMelissa Carver, MSN, AOCN, APRN Genentech, A Member of the Roche Group |
Tuesday, October 20 | |
2:00 pm– 2:45 pm ET |
Venetoclax AML Patient Management: Practical Guidance for Advanced Practice Oncology ProvidersGlen J. Peterson, DNP, ACNP AbbVie |
Wednesday, October 21 | |
12:30 pm– 1:15 pm ET |
Treating Patients with Advanced Prostate Cancer: mCSPC and nmCRPCKaylinn Musto, NP Janssen Biotech, Inc. |
Thursday, October 22 | |
3:45 pm– 4:30 pm ET |
CABOMETYX®: Clinical Management of Advanced RCC and HCCKimberly Allman, MSN, CNP, OCN Exelixis, Inc. |
Friday, October 23 | |
11:45 am– 12:30 pm ET |
First Line Ovarian Cancer Maintenance TherapyKimberly Halla, FNP GSK |
October 26 – November 6 | |
Monday, October 26 | |
1:00 pm – 1:45 pm ET |
A treatment regimen for previously treated adults with BRAFmt metastatic colorectal cancerShanetia S. Avinger, DNP, MSN, APRN, FNP-C Pfizer Oncology |
Wednesday, October 28 | |
12:45 pm – 1:30 pm ET |
Important Treatment Considerations for Patients with Relapsed or Refractory Multiple MyelomaPatricia A. Mangan, APRN-BC GSK |
Friday, October 30 | |
12:45 pm – 1:30 pm ET |
CAR T Cell Therapy: The Science and the Patient JourneyReiko Torgeson, MN, RN, OCN Carly Borchert, MSN, RN, OCN Bristol Myers Squibb |
Tuesday, November 3 | |
4:00 pm – 4:45 pm ET |
Redefining Approaches in Early Line Multiple Myeloma TreatmentJill D. Avery, DNP, APN-BC, ACNP, AOCNP Janssen Biotech, Inc. |